Ivy Noah

Type 1 diabetes in children is a state in which your child's body cannot produce an important hormone called insulin. Your child requires insulin to survive, and the quantity of insulin needed by the body must be replaced with injections or with the help of an insulin pump. Type 1 diabetes in children is known as juvenile diabetes or insulin-dependent diabetes. The diagnosis of type 1 diabetes in children can be challenging, especially soon after diagnosis. You and your child, considering his or her age, must learn to live the lifestyle of injections, counting carbohydrates, and monitoring blood sugar. There's no cure, only management for type 1 diabetes in children. Latest advancements in blood sugar monitoring and insulin delivery have improved blood sugar administration and eased the life of children with type 1 diabetes. Symptoms of diabetes in children The signs and symptoms of type 1 diabetes in children are shown very quickly and may include: Feeling thirsty Frequent uri

By now, you might be aware of the health concerns caused by SARS-CoV-2, the COVID-19 virus. After some studies conducted, it has been identified that some people can develop diabetes after an acute COVID-19 infection. Type 1 diabetes happens when pancreatic beta cells don't produce sufficient insulin to help the body metabolize food optimally after a meal. As a consequence of this insulin shortage, blood glucose levels go up the hallmark of diabetes. The previously conducted lab studies had indicated that SARS-CoV-2 can contaminate human beta cells. It also shows that this destructive virus can reproduce in these insulin-producing beta cells to make more replicas of itself and get distributed to other cells.  The new discoveries tells that the coronavirus infection alters the operation of islets—the pancreatic tissue that has beta cells. Infection with SARS-CoV-2 leads to lowered production and release of insulin from pancreatic islet tissue. It can directly influence the end of so

According to experts at a KFAS-affiliated institution, more awareness of uncommon, hereditary types of diabetes is needed across the Middle East and North Africa (MENA) in order for patients to receive the best possible therapy. People with maturity-onset diabetes of the young (MODY) are frequently misdiagnosed, according to experts at the Dasman Diabetes Institute in Kuwait City, since many clinicians are ignorant of how it varies from more prevalent types of the condition. When compared to the more frequent type 1 and type 2 diabetes, MODY is an uncommon and lesser-known kind of diabetes. It's a hereditary condition that tends to run in families and manifests itself at an early age. Professor Fahd Al-Mulla and colleagues, in a letter published in The Lancet Diabetes & Endocrinology, asked for more awareness of MODY and improved access to genetic testing in Kuwait. The Middle East and North Africa (MENA) area has among of the world's highest diabetes rates. In Kuwait, one

According to research from a Kuwaiti study team, high blood sugar levels may be a predictor of COVID-19 severity.  A recent study utilizing a new statistical modelling approach links fasting blood glucose in COVID-19 patients to coronavirus severity and the chance of being hospitalized to the critical care unit. Patients are often categorized into three groups depending on their fasting blood sugar levels, according to the American Diabetes Association: non-diabetic, prediabetic, and diabetic, which is both clinically and statistically handy. "If you have this value clinically, you belong to this category," Hamad Ali of Kuwait University's Health Sciences Center explained. "Your care will rely on the three categories, such as modifying your diet or taking an antidiabetic medicine." "Statistically, we've been using these classifications, or the dichotomy of diabetic vs nondiabetic, to pose questions like, 'What is the chance of severe COVID if you fa

Prof. Fahd Al Mulla and his colleagues are looking into why certain COVID-19 instances are more severe than others. The heterogeneity in outcome, which spans from quiet infection in some patients to mortality in others, as well as the 'extended COVID' that some patients experience, has been a remarkable characteristic of COVID-19. This heterogeneity is unsurprising for a novel illness spreading fast through a varied population, but knowing what drives it would be crucial in determining how to deal with the pandemic and limit its effects. Although older persons, men, and those with underlying medical issues are more likely to have severe COVID-19 infections, these characteristics do not account for the wide range of outcomes. In some individuals, an international team of experts theorized that inborn mutations in immune-related genes may be associated to the development of life-threatening COVID-19. To investigate this theory, they formed the COVID Human Genetic Effort, an inter